​​This study aims to identify distinct metabolite profiles associated with insulin resistance (IR) and type 2 diabetes mellitus (T2DM) in individuals with ischemic heart disease (IHD). Utilizing untargeted metabolomics through liquid chromatography-tandem mass spectrometry (LC-MS/MS), we will analyze serum samples to uncover metabolic pathway alterations in IHD patients with IR or T2DM compared to non-IHD participants. The goal is to discover novel biomarkers that can aid in the early diagnosis of IHD, assess disease severity, and support the monitoring of therapeutic response.

The Project is Funded by The Deanship of Scientific Research/ Jordan University of Science and Technology (JD 6000)​